Results 141 to 150 of about 5,544 (172)
Some of the next articles are maybe not open access.
[Gout: an overview of available urate lowering therapies].
Annales pharmaceutiques francaises, 2012The aim of urate-lowering therapy is to maintain urate concentration below the saturation point for monosodium urate. This therapy dissolves crystal deposits and cures gout while it is maintained. EULAR guidelines recommend that plasma urate should be maintained at a concentration less than 360μM, and the British Guidelines less than 300μM.
openaire +2 more sources
Urate-Lowering Therapy for the Management of Gout: A Summary of 2 Cochrane Reviews
The Journal of Rheumatology Supplement, 2014To systematically review the evidence on the efficacy, safety, and cost-effectiveness of urate-lowering therapy for gout: xanthine oxidase inhibitors (allopurinol and febuxostat), uricosuric medications (benzbromarone, probenecid and sulfinpyrazone), and uricases (pegloticase and rasburicase).A systematic review was performed as part of the 3e ...
Kydd, A.S. +6 more
openaire +3 more sources
Response to “Urate lowering therapy for patients with gout on hemodialysis”
International Journal of Rheumatic Diseases, 2022Reem Alkilany +2 more
openaire +2 more sources
Benefits of urate-lowering therapy in asymptomatic hyperuricemia
Evidence-Based Practice, 2022Alexandria Cooke, Hannah King
openaire +1 more source
Initiation of Urate Lowering Therapy (ULT)
The Singapore Family Physician, 2022openaire +1 more source
Initiation of Urate Lowering Therapy (ULT)
The Singapore Family Physician, 2021openaire +1 more source
Gradual reduction of tophaceous deposits during urate-lowering therapy
Joint Bone Spine, 2021Sara Nysom Christiansen +3 more
openaire +3 more sources